OR WAIT null SECS
May 23, 2018
The new company will develop proprietary RNA-based therapeutics and will provide broad lentiviral development and manufacturing expertise and support.
May 09, 2018
The companies expanded their partnership to develop and commercialize messenger RNA (mRNA) cancer vaccines to include shared-antigen mRNA cancer vaccines such as mRNA-5671.
Takeda expands its global and therapy base with announced acquisition of Shire.
April 19, 2018
The transaction is part of Merck KGaA’s strategy to actively shape its product portfolio and focus on innovation-driven business.
Global investment firm Advent to acquire and invest in Sanofi’s European generics business, Zentiva, to boost its position in European market.
Johnson & Johnson’s Janssen partners with Bristol-Myers Squibb to advance next-generation therapies for cardiovascular diseases.
April 16, 2018
Under an Innovate UK grant for a three-year project, Arcinova and the University of Nottingham will develop a continuous, flexible modular manufacturing technology platform.
April 12, 2018
The new facility, to be built in Toronto, Canada, will significantly increase capacity for pediatric and booster vaccines.
ReForm Biologics and KBI Biopharma will collaborate to improve biopharmaceutical formulations and development.
April 11, 2018
The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.